Results 171 to 180 of about 1,923,312 (279)
Respiratory syncytial virus: current and emerging treatment options
Tiffany L Turner,1 Benjamin T Kopp,1 Grace Paul,1 Lindsay C Landgrave,2 Don Hayes Jr,1 Rohan Thompson11Department of Pediatrics, Ohio State University College of Medicine, 2Clinical Pharmacy, Nationwide Children's Hospital, Columbus, OH, USAAbstract:
Thompson R +5 more
core
The development of recombinant Adenoviral vaccines to target pneumovirus infection [PDF]
Respiratory Syncytial Virus (RSV) is a member of the pneumovirus genus (family Paramyxoviridae, subfamily Pneumovirinae). RSV is an important respiratory virus of both infants and the elderly, representing an underappreciated burden on health care ...
Terry, Helen Elizabeth
core
Abstract Precision‐cut lung slices (PCLS) represent a physiologically relevant ex vivo model that bridges the gap between simplified in vitro systems and in vivo animal studies by preserving native lung architecture, cellular diversity, and functional responses.
Asal Ahmadi +7 more
wiley +1 more source
Coinfection by influenza A virus and respiratory syncytial virus produces hybrid virus particles
Joanne Haney +9 more
semanticscholar +1 more source
ABSTRACT Aims Especially, the coxsackievirus B group of enteroviruses has been linked to the development of islet autoimmunity and type 1 diabetes in genetically susceptible individuals. Our aim was to study the possible associations of 10 different microbial infections with islet autoimmunity in a large international prospective study.
Maarit Oikarinen +14 more
wiley +1 more source
ABSTRACT Human metapneumovirus (HMPV) is a respiratory virus that predominantly affects the pediatric population. Its role as an infective agent in ear, nose, and throat (ENT) diseases is not yet well understood. To systematically review the available literature on the association between HMPV and ENT manifestations, following PRISMA guidelines, a ...
Ali Gohar +12 more
wiley +1 more source
SARS‐CoV‐2 infection drives transient B‐cell remodeling toward an activated, regulatory‐like phenotype. In this randomized sub‐study, the polyclonal neutralizing antibody XAV‐19 did not detectably alter B‐cell phenotype, transcriptome, or function relative to placebo, indicating that passive polyclonal therapy preserves B‐cell homeostasis during acute ...
Nicolas Degauque +19 more
wiley +1 more source
ABSTRACT Background and Aims Severe acute respiratory infections (SARI) remain a major cause of global morbidity and mortality, with a disproportionate burden in low‐ and middle‐income countries (LMICs). Although in‐hospital mortality is frequently reported, deaths occurring after hospital discharge remain poorly documented.
Md Ariful Islam +7 more
wiley +1 more source
RSV Monoclonal Antibody Implementation for At‐Risk Infants: Victoria, Australia's 2024 Experience
ABSTRACT Background New respiratory syncytial virus (RSV) preventative programs are launching globally. Our Australian jurisdiction implemented RSV monoclonal antibody provision via pediatric and perinatal hospitals for highest risk neonates and infants.
Jane Tuckerman +8 more
wiley +1 more source
Epidemiology of Human Metapneumovirus Infection—A Systematic Review and Meta‐Analysis
ABSTRACT Background Human metapneumovirus (hMPV) is a globally circulating respiratory pathogen. The objective of this systematic review is to evaluate the prevalence, case fatality rate, age‐related severity, and seasonality of hMPV in the group of Acute Respiratory Infections (ARIs) and Community‐Acquired Pneumonia (CAP).
Sumaiya Tasnim +3 more
wiley +1 more source

